Oxazepam is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Trupharma, Llc. The primary component is Oxazepam.
| Product ID | 52817-292_0bb751ed-e01b-4fe6-bde4-511bfd3aebbc |
| NDC | 52817-292 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Oxazepam |
| Generic Name | Oxazepam |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-03-19 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA071026 |
| Labeler Name | TruPharma, LLC |
| Substance Name | OXAZEPAM |
| Active Ingredient Strength | 30 mg/1 |
| Pharm Classes | Benzodiazepine [EPC],Benzodiazepines [CS] |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2020-03-19 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA071026 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-03-19 |
| Ingredient | Strength |
|---|---|
| OXAZEPAM | 30 mg/1 |
| SPL SET ID: | bda8bc70-3328-46f2-89d5-7ef7a061b418 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0228-2067 | Oxazepam | Oxazepam |
| 0228-2069 | Oxazepam | Oxazepam |
| 0228-2073 | Oxazepam | Oxazepam |
| 0781-2809 | Oxazepam | Oxazepam |
| 0781-2810 | Oxazepam | Oxazepam |
| 0781-2811 | Oxazepam | Oxazepam |
| 43353-074 | Oxazepam | Oxazepam |
| 43353-965 | Oxazepam | Oxazepam |
| 43353-980 | Oxazepam | Oxazepam |
| 52817-290 | Oxazepam | Oxazepam |
| 52817-291 | Oxazepam | Oxazepam |
| 52817-292 | Oxazepam | Oxazepam |
| 62584-812 | Oxazepam | Oxazepam |
| 62584-813 | Oxazepam | Oxazepam |
| 62584-814 | Oxazepam | Oxazepam |
| 67544-294 | Oxazepam | Oxazepam |
| 67544-117 | Oxazepam | Oxazepam |
| 67544-268 | Oxazepam | Oxazepam |